# Quality Assurance Report

---

# Identity

| Field | Value |
|-------|-------|
| QA Report ID | QA-PP-0146 |
| Population Package | PP-0146 |
| Version | 1.0.0 |
| Review Status | PASS |

---

# Layer 1 — Content QA

| Criterion | Result |
|-----------|--------|
| Single educational question | PASS |
| Scope respected | PASS |
| Complete coverage | PASS |
| Internal consistency | PASS |
| Logical organization | PASS |
| Knowledge blocks complete | PASS |
| No overlap with adjacent Population Packages | PASS |
| Atomic Knowledge Principle preserved | PASS |

---

# Layer 2 — Clinical QA

| Criterion | Result |
|-----------|--------|
| Scientifically accurate | PASS |
| Consistent with ACMG | PASS |
| Consistent with AMP | PASS |
| Consistent with ClinGen SVI principles | PASS |
| Appropriate disease-specific interpretation | PASS |
| Appropriate explanation of age | PASS |
| Appropriate explanation of penetrance | PASS |
| Appropriate explanation of inheritance pattern | PASS |
| Appropriate explanation of phenotyping | PASS |
| Healthy adult not equated with automatic benignity | PASS |
| Reduced penetrance appropriately addressed | PASS |
| Late-onset disease appropriately addressed | PASS |
| No unsupported clinical claim | PASS |
| No unsafe medical advice | PASS |

---

# Layer 3 — Educational QA

| Criterion | Result |
|-----------|--------|
| Plain language | PASS |
| Appropriate for gastric-cancer patients and caregivers | PASS |
| Learning objectives satisfied | PASS |
| Common misconceptions addressed | PASS |
| Healthy-carrier misconception explicitly corrected | PASS |
| Age concept explained | PASS |
| Penetrance concept explained | PASS |
| Disease-specific context explained | PASS |
| Technical implementation appropriately deferred | PASS |

---

# Layer 4 — Governance QA

| Criterion | Result |
|-----------|--------|
| CKO completed | PASS |
| Knowledge Passport completed | PASS |
| Evidence Package completed | PASS |
| Evidence traceability complete | PASS |
| Scope maintained | PASS |
| Knowledge Graph complete | PASS |
| Gastric-cancer system context preserved | PASS |
| Versioning complete | PASS |
| Repository compliant | PASS |

---

# Clinical Safety Review

| Item | Result |
|------|--------|
| No unsafe medical advice | PASS |
| No automatic benign classification implied | PASS |
| No universal BS2 rule presented | PASS |
| Age and penetrance emphasized | PASS |
| Inheritance pattern emphasized | PASS |
| Adequate phenotyping emphasized | PASS |
| Reduced penetrance appropriately handled | PASS |
| Late-onset disease appropriately handled | PASS |
| Hereditary gastric-cancer context preserved | PASS |
| No treatment recommendations | PASS |

---

# Educational Boundary Review

The Population Package remains within the predefined educational boundary.

### Included

- BS2 definition
- Healthy adult observation
- Age
- Penetrance
- Inheritance pattern
- Genotype
- Phenotyping
- Disease-specific interpretation
- Hereditary gastric-cancer context

### Excluded

- Disease-specific numerical thresholds
- Detailed penetrance calculations
- Age-dependent penetrance modelling
- Genotype-counting methodology
- gnomAD technical methodology
- BS2_Strong / BS2_Supporting
- Detailed VCEP specifications
- Bayesian framework
- ACMG evidence combination
- BA1
- Laboratory workflow
- Treatment recommendations

The **Atomic Knowledge Principle** has been fully preserved.

---

# Runtime Safety Review

The package establishes the following safety boundary:

> **A healthy adult carrying a variant does not automatically make the variant benign.**

The Safe Medical AI System must avoid statements such as:

- "The variant is benign because it was found in a healthy person."
- "Any healthy adult can be used for BS2."
- "BS2 applies equally to every hereditary gastric-cancer syndrome."

Instead, the system should communicate that BS2 depends on:

- the specific disorder;
- genotype;
- inheritance pattern;
- age;
- penetrance;
- expected disease onset;
- adequate clinical evaluation.

---

# Final Quality Decision

## PASS

PP-0146 satisfies the locked **Gold Population Package Specification v1.0**.

Approved as the official Population Package for:

> **PP-0146 — BS2 (Observed in Healthy Adults Without the Disease)**

---

# Reviewer Notes

This Population Package preserves the key clinical distinction between:

**"variant observed in a healthy adult"**

and

**"evidence that the variant is benign."**

The distinction is particularly important in hereditary gastric-cancer interpretation because penetrance and age of onset can differ substantially between cancer-predisposition disorders.

The package therefore keeps BS2 at the correct patient-facing conceptual level while deferring disease-specific implementation and technical penetrance modelling to dedicated Population Packages.

The package maintains strict adherence to the **Atomic Knowledge Principle** and the locked **Gold Workflow**.